FRANCESCHINI, GUIDO
FRANCESCHINI, GUIDO
Dipartimento di Scienze per gli Alimenti, la Nutrizione e l'Ambiente
Recombinant LCAT (Lecithin:Cholesterol Acyltransferase) Rescues Defective HDL (High-Density Lipoprotein)-Mediated Endothelial Protection in Acute Coronary Syndrome
2019 A. Ossoli, S. Simonelli, M. Varrenti, N. Morici, F. Oliva, M. Stucchi, M. Gomaraschi, A. Strazzella, L. Arnaboldi, M.J. Thomas, M.G. Sorci-Thomas, A. Corsini, F. Veglia, G. Franceschini, S.K. Karathanasis, L. Calabresi
High Density Lipoproteins Inhibit Oxidative Stress-Induced Prostate Cancer Cell Proliferation
2018 M. Ruscica, M. Botta, N. Ferri, E. Giorgio, C. Macchi, G. Franceschini, P. Magni, L. Calabresi, M. Gomaraschi
Complete and partial LCAT deficiency are differentially associated with atherosclerosis
2018 F. Oldoni, D. Baldassarre, S. Castelnuovo, A. Ossoli, M. Amato, J. van Capelleveen, G.K. Hovingh, E. de Groot, A. Bochem, S. Simonelli, S. Barbieri, F. Veglia, G. Franceschini, J.A. Kuivenhoven, A.G. Holleboom, L. Calabresi
Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency
2017 M. Gomaraschi, A. Ossoli, S. Castelnuovo, S. Simonelli, C. Pavenello, G. Balzarotti, M. Arca, A. Di Costanzo, T. Sampietro, G. Vaudo, D. Baldassarre, F. Veglia, G. Franceschini, L. Calabresi
Role of LCAT in atherosclerosis
2016 A. Ossoli, S. Simonelli, C. Vitali, G. Franceschini, L. Calabresi
High density lipoproteins inhibit oxidative stress-induced prostate cancer cell proliferation
2016 M. Ruscica, M. Botta, N. Ferri, C. Songia, G. Franceschini, L. Calabresi, P. Magni, M. Gomaraschi
Protective effects of HDL against ischemia/reperfusion injury
2016 M. Gomaraschi, L. Calabresi, G. Franceschini
Lipoprotein X causes renal disease in LCAT deficiency
2016 A. Ossoli, E.B. Neufeld, S.G. Thacker, B. Vaisman, M. Pryor, L.A. Freeman, C.A. Brantner, I. Baranova, N.O. Francone, S.J. Demosky, C. Vitali, M. Locatelli, M. Abbate, C. Zoja, G. Franceschini, L. Calabresi, A.T. Remaley
Deficit di lecitina:colesterolo aciltransferasi: dalla genetica alla terapia
2016 F. Lucca, A. Ossoli, G. Boscutti, G. Franceschini, L. Calabresi
Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome
2015 M. Gomaraschi, A. Ossoli, M.P. Adorni, E. Damonte, E. Niesor, F. Veglia, G. Franceschini, R. Benghozi, L. Calabresi
Acquired lecithin :cholesterol acyltransferase deficiency as a major factor in lowering plasma HDL levels in chronic kidney disease
2015 L. Calabresi, S. Simonelli, P. Conca, G. Busnach, M. Cabibbe, L. Gesualdo, M. Gigante, S. Penco, F. Veglia, G. Franceschini
Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function
2015 M. Gomaraschi, M.P. Adorni, M. Banach, F. Bernini, G. Franceschini, L. Calabresi
Beta2-adrenergic activity modulates vascular tone regulation in lecithin : cholesterol acyltransferase knockout mice
2015 S. Manzini, C. Pinna, M. Busnelli, P. Cinquanta, E. Rigamonti, G.S. Ganzetti, F. Dellera, A. Sala, L. Calabresi, G. Franceschini, C. Parolini, G. Chiesa
Vascular alterations in apolipoprotein A-I amyloidosis (Leu75Pro) : a case-control study
2015 M.L. Muiesan, M. Salvetti, A. Paini, C. Agabiti Rosei, G. Rubagotti, A. Negrinelli, G. Gregorini, G. Cancarini, L. Calabresi, G. Franceschini, L. Obici, S. Perlini, G. Merlini, E.A. Rosei
HDL and atherosclerosis : insights from inherited HDL disorders
2015 L. Calabresi, M. Gomaraschi, S. Simonelli, F. Bernini, G. Franceschini
Genetic determinants of HDL metabolism
2014 A. Ossoli, M. Gomaraschi, G. Franceschini, L. Calabresi
Distant Homology Modeling of LCAT and Its Validation through In Silico Targeting and In Vitro and In Vivo Assays
2014 C. Sensi, S. Simonelli, I. Zanotti, G. Tedeschi, G. Lusardi, G. Franceschini, L. Calabresi, I. Eberini
eNOS activation by HDL is impaired in genetic CETP deficiency
2014 M. Gomaraschi, A. Ossoli, S. Pozzi, P. Nilsson, A.B. Cefalù, M. Averna, J.A. Kuivenhoven, G..K. Hovingh, F. Veglia, G. Franceschini, L. Calabresi
Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients
2013 G. Franceschini, E. Favari, L. Calabresi, S. Simonelli, A. Bondioli, M. Adorni, F. Zimetti, M. Gomaraschi, K. Coutant, S. Rossomanno, E. Niesor, F. Bernini, R. Benghozi
Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency
2013 S. Simonelli, C. Tinti, L. Salvini, L. Tinti, A. Ossoli, C. Vitali, V. Sousa, G. Orsini, M.L. Nolli, G. Franceschini, L. Calabresi